Ad is loading...
NWFFX
Price
$79.56
Change
-$0.78 (-0.97%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

NWFFX vs RNWFX

Header iconNWFFX vs RNWFX Comparison
Open Charts NWFFX vs RNWFXBanner chart's image
American Funds New World F1
Price$79.56
Change-$0.78 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
NWFFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWFFX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWFFX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
NWFFX (60.9B) and RNWFX (60.9B) have equal amount of cash in the bank . RNWFX pays higher dividends than NWFFX: RNWFX (1.51) vs NWFFX (1.18). NWFFX was incepted earlier than RNWFX: NWFFX (24 years) vs RNWFX (23 years). NWFFX (32.00) and RNWFX (32.00) have comparable annual turnover. NWFFX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX (11.54) and NWFFX (11.14) have marching annual gain over last year. RNWFX return over 5 years is better than : 17.17 vs. NWFFX (16.16).
NWFFXRNWFXNWFFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD6.7787.09995%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRA250N/A-
Net Assets60.9B60.9B100%
Annual Yield % from dividends1.181.5178%
Returns for 1 year11.1411.5497%
Returns for 3 years-15.15-14.55104%
Returns for 5 years16.1617.1794%
Returns for 10 years39.3241.0096%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics